ArticleFrontiers in psychiatry2025
Impairment in social cognition in people with substance use disorders.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Substance use disorders are associated with impairments in various neuropsychological functions. We evaluated potential alterations in social cognition and differences between men and women in individuals with substance use disorders undergoing treatment at Addiction and Dependency Intervention Centers in Portugal. Methods: The assessment utilized the Ekman 60 Faces Test (EFT), Interpersonal Reactivity Index (IRI), Hinting Task, and Ambiguous Intentions Hostility Questionnaire (AIHQ). Results: Results showed that 70.2% of participants exhibited social cognition impairments (50% of women and 79.5% of men). Compared to non-clinical populations, individuals with social cognition impairments displayed significant differences in recognizing emotions such as happiness, fear, sadness, disgust, anger, and in the total EFT score. Differences were also observed in the fantasy and personal distress dimensions of the IRI, as well as in hostility, intentionality, and aggression biases on the AIHQ. Slight differences were found between men and women, but were not statistically significant. Discussion: We discuss the clinical relevance of social cognition alterations and their potential utility in improving diagnostic and therapeutic processes for individuals with substance use disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.